Literature DB >> 18601823

[Cardiovascular mortality attributable to high blood pressure in Spanish population over 50].

Auxiliadora Graciani1, María Clemencia Zuluaga-Zuluaga, José R Banegas, Luz María León-Muñoz, Juan J de la Cruz, Fernando Rodríguez-Artalejo.   

Abstract

BACKGROUND AND
OBJECTIVE: Cardiovascular mortality attributable to high blood pressure in Spain is not available at present. PATIENTS AND
METHOD: Population attributable risk and number of cardiovascular deaths attributable to high systolic blood pressure (> or = 120 mmHg) were estimated for the Spanish population aged 50-89 years, according to classical formulae. Relative risk data were drawn from the Prospective Studies Collaboration, meta-analysis of 61 studies on blood pressure and mortality, with data on one million subjects (30,000 from South Europe) with no prior vascular disease. Blood pressure prevalence was drawn from 2 nationwide surveys in Spain, for subjects aged 50-59 years and 60-89 years old, respectively. Cardiovascular deaths occurred in Spain were drawn from official statistics (year 2004).
RESULTS: The number of annual cardiovascular deaths attributable to high blood pressure was 44,401, which represents 54% of the carFdiovascular deaths occurred in people over 50 years: 17,312 for ischemic heart disease, 15,599 for stroke, and 11,490 for other cardiovascular diseases. The highest number of attributable deaths lie in hypertension grade 1 and 2 (32,638) and in those over 70 years (36,345). Normal and high-normal blood pressure accounted for 6% of all attributable cardiovascular deaths.
CONCLUSIONS: One in 2 cardiovascular deaths occurred annually in Spanish individuals over 50 years are attributable to high blood pressure, 90% of them are attributable to hypertension.

Entities:  

Mesh:

Year:  2008        PMID: 18601823     DOI: 10.1157/13124098

Source DB:  PubMed          Journal:  Med Clin (Barc)        ISSN: 0025-7753            Impact factor:   1.725


  6 in total

1.  [Fixed drug combinations in hypertension: a budget impact analysis for the Spanish Health System on the marketing of a fixed combination of olmesartan/amlodipine].

Authors:  M Belén Ferro-Rey; Alex Roca-Cusachs; Antoni Sicras-Mainar; Carlos Alvarez-Martín; Marina de Salas-Cansado
Journal:  Aten Primaria       Date:  2011-01-08       Impact factor: 1.137

2.  Intervention for control of hypertension in Catalonia, Spain (INCOTECA Project): results of a multicentric, non-randomised, quasi-experimental controlled intervention study.

Authors:  Roser Vallès-Fernández; Teresa Rodriguez-Blanco; Lucas Mengual-Martínez; Magdalena Rosell-Murphy; Gemma Prieto-De Lamo; Fina Martínez-Frutos; Sonia Mimoso-Moreno; Eva Bellerino-Serrano; Alícia Alvarez-Lázaro; Alícia Franzi-Sisó; Juan Carlos Martínez-Vindel; M Socorro Alonso-Ortega; Imma Olmedo-Muñoz; Josep M Bonet-Simó
Journal:  BMJ Open       Date:  2012-04-18       Impact factor: 2.692

3.  The burden of blood-pressure-related cardiovascular mortality in Mexico.

Authors:  Dora E Cortés-Hernández; Krista J Lundelin; Esteban Picazzo-Palencia; Juan J de la Cruz; José J Sánchez; José R Banegas
Journal:  Int J Hypertens       Date:  2014-02-10       Impact factor: 2.420

4.  Validity of self blood pressure measurement in the control of the hypertensive patient: factors involved.

Authors:  Arleen De León-Robert; Juan José Gascón-Cánovas; José Joaquín Antón-Botella; Isabel María Hidalgo-García; Carmen López-Alegría; Yoalys Dilvani Pérez-Cabrera; Heidy Merari Campusano-Castellanos
Journal:  BMC Cardiovasc Disord       Date:  2019-07-17       Impact factor: 2.298

5.  [Impact of cardiovascular risk factors in the Extremadura population: HERMEX cohort contributions for a preventive strategy].

Authors:  Francisco Javier Félix-Redondo; Luis Lozano Mera; Paula Alvarez-Palacios Arrighi; Maria Grau Magana; Jose María Ramírez-Romero; Daniel Fernández-Bergés
Journal:  Aten Primaria       Date:  2019-01-10       Impact factor: 1.137

6.  A quality improvement plan for hypertension control: the INCOTECA Project (INterventions for COntrol of hyperTEnsion in CAtalonia).

Authors:  Roser Vallès-Fernandez; Magdalena Rosell-Murphy; Olga Correcher-Aventin; Lucas Mengual-Martínez; Núria Aznar-Martínez; Gemma Prieto-De Lamo; Alícia Franzi-Sisó; Jordi Puig-Manresa; Josep Ma Bonet-Simó
Journal:  BMC Public Health       Date:  2009-03-25       Impact factor: 3.295

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.